Cogent Biosciences, Inc. (COGT)
36.25
+1.47
(+4.23%)
USD |
NASDAQ |
Jan 07, 16:00
36.25
0.00 (0.00%)
After-Hours: 18:09
Cogent Biosciences Research and Development Expense (Annual): 228.26M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Ionis Pharmaceuticals, Inc. | 901.53M |
| Cidara Therapeutics, Inc. | 71.88M |
| Olema Pharmaceuticals, Inc. | 124.52M |
| ADMA Biologics, Inc. | 1.813M |